Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary Shares
Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021     157,237,435          
Beginning balance at Dec. 31, 2021 $ 1,081,618 $ (1,545) $ 157,237 $ 0 $ 1,670,033 $ (7,135) $ (738,517) $ (1,545)
Beginning balance (in shares) at Dec. 31, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 4,963       4,963      
Ordinary shares issued related to founders advisory fees - related party (in shares)     5,952,992          
Ordinary shares issued related to founders advisory fees - related party 13,783   $ 5,954   7,829      
Ordinary share issued related to warrants exercised (in shares)     44,115          
Ordinary share issued related to warrants exercised 529   $ 44   485      
Net income 36,963           36,963  
Other comprehensive income (loss) 126         126    
Ending balance (in shares) at Mar. 31, 2022     163,234,542          
Ending balance at Mar. 31, 2022 1,136,437   $ 163,235 $ 0 1,683,310 (7,009) (703,099)  
Ending balance (in shares) at Mar. 31, 2022       0        
Beginning balance (in shares) at Dec. 31, 2021     157,237,435          
Beginning balance at Dec. 31, 2021 1,081,618 $ (1,545) $ 157,237 $ 0 1,670,033 (7,135) (738,517) $ (1,545)
Beginning balance (in shares) at Dec. 31, 2021       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 45,890              
Ending balance (in shares) at Jun. 30, 2022     163,234,542          
Ending balance at Jun. 30, 2022 1,127,418   $ 163,235 $ (5,008) 1,686,743 (23,380) (694,172)  
Ending balance (in shares) at Jun. 30, 2022       597,513        
Beginning balance (in shares) at Mar. 31, 2022     163,234,542          
Beginning balance at Mar. 31, 2022 1,136,437   $ 163,235 $ 0 1,683,310 (7,009) (703,099)  
Beginning balance (in shares) at Mar. 31, 2022       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 3,433       3,433      
Ordinary shares repurchased (in shares)       597,513        
Ordinary shares repurchased (5,008)     $ (5,008)        
Net income 8,927           8,927  
Other comprehensive income (loss) (16,371)         (16,371)    
Ending balance (in shares) at Jun. 30, 2022     163,234,542          
Ending balance at Jun. 30, 2022 $ 1,127,418   $ 163,235 $ (5,008) 1,686,743 (23,380) (694,172)  
Ending balance (in shares) at Jun. 30, 2022       597,513        
Beginning balance (in shares) at Dec. 31, 2022 156,797,806   163,234,542          
Beginning balance at Dec. 31, 2022 $ 1,138,900   $ 163,235 $ (49,341) 1,698,781 (25,471) (648,304)  
Beginning balance (in shares) at Dec. 31, 2022 6,436,736     6,436,736        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation $ (3,074)       (3,074)      
Ordinary shares issued related to founders advisory fees - related party (in shares)     1,831,653          
Ordinary shares issued related to founders advisory fees - related party 0   $ 1,832   (1,832)      
Ordinary shares repurchased (in shares)       115,570        
Ordinary shares repurchased (864)     $ (864)        
Net income 9,431           9,431  
Other comprehensive income (loss) 1,593         1,593    
Ending balance (in shares) at Mar. 31, 2023     165,066,195          
Ending balance at Mar. 31, 2023 $ 1,145,986   $ 165,067 $ (50,205) 1,693,875 (23,878) (638,873)  
Ending balance (in shares) at Mar. 31, 2023       6,552,306        
Beginning balance (in shares) at Dec. 31, 2022 156,797,806   163,234,542          
Beginning balance at Dec. 31, 2022 $ 1,138,900   $ 163,235 $ (49,341) 1,698,781 (25,471) (648,304)  
Beginning balance (in shares) at Dec. 31, 2022 6,436,736     6,436,736        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 61,445              
Ending balance (in shares) at Jun. 30, 2023 154,520,833   165,066,195          
Ending balance at Jun. 30, 2023 $ 1,175,062   $ 165,067 $ (76,553) 1,695,070 (21,663) (586,859)  
Ending balance (in shares) at Jun. 30, 2023 10,545,362     10,545,362        
Beginning balance (in shares) at Mar. 31, 2023     165,066,195          
Beginning balance at Mar. 31, 2023 $ 1,145,986   $ 165,067 $ (50,205) 1,693,875 (23,878) (638,873)  
Beginning balance (in shares) at Mar. 31, 2023       6,552,306        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 1,195       1,195      
Ordinary shares repurchased (in shares)       3,993,056        
Ordinary shares repurchased (26,348)     $ (26,348)        
Net income 52,014           52,014  
Other comprehensive income (loss) $ 2,215         2,215    
Ending balance (in shares) at Jun. 30, 2023 154,520,833   165,066,195          
Ending balance at Jun. 30, 2023 $ 1,175,062   $ 165,067 $ (76,553) $ 1,695,070 $ (21,663) $ (586,859)  
Ending balance (in shares) at Jun. 30, 2023 10,545,362     10,545,362